AHA Scientific Sessions 2025 Abstract
Walking Impairment Questionnaire score declines after lower extremity revascularization are linked to adverse cardiovascular events and rivaroxaban dose not affect walking ability
Trial in peopleBiomarkers
Papers by Eva Muehlhofer
1 result